Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Developing a metformin prescribing tool for use in adults with mental illness to reduce medication-related weight gain and cardiovascular risk|
|Citation:||Australasian Psychiatry, 2017; 25(4):387-390|
|Cassie Smith, Hannah Myles, Cherrie Galletly|
|Abstract:||Objectives: There is considerable evidence that metformin reduces weight gain associated with antipsychotic medication. The aim of this study was to develop an easy-to-use metformin prescribing tool in order to enable clinicians to prescribe metformin safely and confidently. Methods: The authors undertook a survey of clinicians and reviewed the published literature and existing guidelines concerning the use of metformin to reduce weight gain in adults with mental illness. Results: A metformin prescribing tool was devised based on the literature, national cardiovascular and diabetes guidelines and Australian metformin prescribing recommendations. The metformin prescribing tool guides clinicians through the considerations required for appropriate selection of the target patient population and safe prescription of metformin. Conclusions: A novel, easy-to-use, one-page reference has been developed for busy clinicians that can be laminated and displayed in consulting rooms and psychiatric inpatient units to address weight gain and obesity associated with antipsychotic medications in people with mental illness.|
|Keywords:||Metformin, mental illness; second-generation antipsychotics; weight gain; obesity; type 2 diabetes; metabolic syndrome; cardiovascular risk factors; prescribing|
|Rights:||© The Royal Australian and New Zealand College of Psychiatrists 2017|
|Appears in Collections:||Psychiatry publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.